Skip to main content
Explore URMC
menu

Sally A. Quataert, Ph.D.

Contact Information

Phone Numbers

Office: (585) 273-2454

Faculty Appointments

Biography

Professional Background

Dr. Sally A. Quataert, Director of the Human Immunology Center (HIC) Core Laboratory, is an internationally recognized expert in bioanalytical method development and standardization. She received her Ph.D. in Microbiology from the State University of New York at Buffalo and has over 25 years in the pharmaceutical and medical device fields. Under her leadership and scientific direction, her laboratory at Wyeth Vaccines (formerly Lederle-Praxis Biologicals) established W.H.O. recognized methods for evaluating serological correlates for immune protection with polysaccharide conjugate vaccines for Neisseria meningitis, Haemophilus influenzae, and Streptococcus pneumoniae.

Dr. Quataert has extensive experience in conducting inter-laboratory studies and method validation in support of pre-clinical and clinical testing. She was responsible for all aspects of laboratory regulatory compliance and quality systems management in the performance of clinical trial evaluations for vaccine development at Wyeth. Prior to joining Wyeth, Dr. Quataert worked for Electro-Nucleonics, Inc. and Corning Glass Works in the development of immunodiagnostic tests and monoclonal antibody reagents for the biomedical field. Early in her career, Dr. Quataert's interest focused in developing methods for the evaluation of human immune responses in the field of tumor immunology. Her goals for the HIC Core lab are to reduce to practise the highest quality innovative bioanalytical techniques for evaluation of human immune responses and to assist biomedical researchers in the acquisition and execution of these techniques.

Research

The mission of the Human Immunology Center is to provide expertise for applying new cutting edge immunological techniques from basic animal research through development and standardization to human research. Research in the HIC core laboratory supports exploratory clinical research programs by establishing measures for immune status and response across multiple disciplines and programs.
Standard procedures using 18-color multichromatic flow cytometry for cell analysis and 15-color cell sorting, Elispot, fluorispot and lysispot are available for application to clinical trials including lymphoma, autoimmunity, and infectious disease. New techniques provide insight into T, B, dendritic and antigen presenting cell regulation, activation and interactions. Standardized reagent panels for human cell differentiation and activation markers provide the consistency needed to allow interpretation of complex data from analysis of human immune compartments

Credentials

Education

1974
BA | Elmira College
Biology and Chemistry

1983
MA, Ph.D. | St Univ at Buffalo
Microbiology and Immunology

Post-doctoral Training & Residency

1982 - 1984
University of Connecticut Medical Center PDF Immunology

Publications

Journal Articles

6/12/2023
Simpson EL, Schlievert PM, Yoshida T, Lussier S, Boguniewicz M, Hata T, Fuxench Z, De Benedetto A, Ong PY, Ko J, Calatroni A, Rudman Spergel AK, Plaut M, Quataert SA, Kilgore SH, Peterson L, Gill AL, David G, Mosmann T, Gill SR, Leung DYM, Beck LA. "Rapid Reduction in Staphylococcus aureus in Atopic Dermatitis Subjects Following Dupilumab Treatment." The Journal of allergy and clinical immunology.. 2023 Jun 12; Epub 2023 Jun 12.

3/29/2023
Moore JE, Bloom PC, Chu CC, Bruno JE, Herne CA, Baran AM, Quataert SA, Mosmann TR, Taylor RP, Wallace DS, Elliott MR, Barr PM, Zent CS. "Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions." Leukemia research.. 2023 Mar 29; 129:107072. Epub 2023 Mar 29.

3/24/2023
Aljaffary M, Jang H, Alomeir N, Zeng Y, Alkhars N, Vasani S, Almulhim A, Wu TT, Quataert S, Bruno J, Lee A, Xiao J. "Effects of Nystatin oral rinse on oral Candida species and Streptococcus mutans among healthy adults." Clinical oral investigations.. 2023 Mar 24; Epub 2023 Mar 24.

VIEW ALL PUBLICATIONS